Brief: European Commission Approves Oncopeptides' Pepaxti

Oncopeptides AB

18/08/2022 12:14

Aug 18 (Reuters) - Oncopeptides AB  ONCO.ST :
    * EUROPEAN COMMISSION APPROVES ONCOPEPTIDES' PEPAXTI FOR
TREATMENT
OF PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA
    * ONCOPEPTIDES WILL NOW ADVANCE MARKET ACCESS ACTIVITIES TO
PAVE
WAY FOR A SUCCESSFUL LAUNCH OF PEPAXTI IN GERMANY IN Q4, 2022

Source text for Eikon:  ID:nWkr8qMSJG 
Further company coverage:  ONCO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))